Dimethyl fumarate confers neuroprotection by casein kinase 2 phosphorylation of Nrf2 in murine intracerebral hemorrhage

Neurobiology of Disease

Volumn 82, Issue , 2015, Pages 349-358

  Iniaghe, Loretta O ^a,b   Krafft, Paul R ^a,c   Klebe, Damon W ^a   Omogbai, Eric K I ^b   Zhang, John H ^a,c   Tang, Jiping ^a  

^a LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF BENIN   (Nigeria)

^c LOMA LINDA UNIVERSITY   (United States)

Author keywords

Casein kinase 2; Dimethyl fumarate; Evans blue extravasation; Inflammation; Intracerebral hemorrhage; Musculo aponeurotic fibrosarcoma G; Phosphorylated nuclear factor erythroid 2 related factor 2 (Nrf2)

Indexed keywords

3 (2,3,4,5 TETRABROMOPHENYL)ACRYLIC ACID; ACRYLIC ACID; CASEIN KINASE II; CLOSTRIDIOPEPTIDASE A; EVANS BLUE; FUMARIC ACID DIMETHYL ESTER; INTERCELLULAR ADHESION MOLECULE 1; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR NRF2; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1; (E)-3-(2,3,4,5-TETRABROMOPHENYL)ACRYLIC ACID; ACRYLIC ACID DERIVATIVE; COLLAGENASE; ICAM1 PROTEIN, MOUSE; MAFG PROTEIN, MOUSE; NEUROPROTECTIVE AGENT; NFE2L2 PROTEIN, MOUSE; PROTEIN KINASE INHIBITOR; REPRESSOR PROTEIN; TRANSCRIPTION FACTOR MAFG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN EDEMA; BRAIN HEMORRHAGE; CONTROLLED STUDY; DIMERIZATION; DISEASE COURSE; DRUG MECHANISM; FIBROSARCOMA; HEMATOMA; INFLAMMATION; MALE; MICROGLIA; MOUSE; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; WATER CONTENT; ANIMAL; ANTAGONISTS AND INHIBITORS; CEREBRAL HEMORRHAGE; DISEASE MODEL; DRUG EFFECTS; ENZYMOLOGY; GENETICS; IMMUNOMODULATION; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY;

ACRYLATES; ANIMALS; BLOOD-BRAIN BARRIER; BRAIN EDEMA; CASEIN KINASE II; CEREBRAL HEMORRHAGE; COLLAGENASES; DIMETHYL FUMARATE; DISEASE MODELS, ANIMAL; INTERCELLULAR ADHESION MOLECULE-1; MAFG TRANSCRIPTION FACTOR; MALE; MICE; MICROGLIA; NEUROIMMUNOMODULATION; NEUROPROTECTIVE AGENTS; NF-E2-RELATED FACTOR 2; PHOSPHORYLATION; PROTEIN KINASE INHIBITORS; REPRESSOR PROTEINS;

EID: 84937899911     PISSN: 09699961     EISSN: 1095953X     Source Type: Journal    
DOI: 10.1016/j.nbd.2015.07.001     Document Type: Article

References (56)

1. Apopa P.L., He X., Qiang Ma Q. Phosphorylation of Nrf2 in the transcription activation domain by casein kinase 2 (CK2) is critical for the nuclear translocation and transcription activation function of Nrf2 in IMR-32 neuroblastoma cells. J. Biochem. Mol. Toxicol. 2008, 22:63-76.
2. Aronowski J., Hall C.E. New horizons for primary intracerebral hemorrhage treatment: experience from preclinical studies. Neurol. Res. 2005, 27:268-278.
3. Baird L., Dinkova-Kostova A.T. The cytoprotective role of the Keap1-Nrf2 pathway. Arch. Toxicol. 2011, 85:241-272.
4. Bondeson J., Sundle R. Auranofin inhibits the induction of interleukin 1 beta and tumor necrosis factor alpha mRNA in macrophages. Biochem. Pharmacol. 1995, 50:1753-1759.
5. Chen X.L., Dodd G., Thomas S., Zhang X., Wasserman M.A., Rovin B.H., Kunsch C. Activation of Nrf2/ARE pathway protects endothelial cells from oxidant injury and inhibits inflammatory gene expression. Am. J. Physiol. Heart Circ. Physiol. 2006, 290:1862-1870.
6. Chen W., Ma Q., Suzuki H., Hartman R., Tang J., Zhang J.H. Osteopontin reduced hypoxia-ischemia neonatal brain injury by suppression of apoptosis in a rat pup model. Stroke 2011, 42:764-769.
7. Chen Q., Zhang J., Guo J., Tang J., Tao Y., Li L., et al. Chronic hydrocephalus and perihematomal tissue injury developed in a rat model of intracerebral hemorrhage with ventricular extension. Translat. Stroke Res. 2014, 10.1007/s12975-014-0367-5.
8. Chen S., Yang Q., Chen G., Zhang J.H. An update on inflammation in the acute phase of intracerebral hemorrhage. Translat. Stroke Res. 2015, 6:4-8.
9. de Jong R., Bezemer A.C., Zomerdijk T.P., van de Pouw-Kraan T., Ottenhoff T.H., Nibbering P.H. Selective stimulation of T helper 2 cytokine responses by the anti-psoriasis agent monomethylfumarate. Eur. J. Immunol. 1996, 26:2067-2074.
10. Garcia J.H., Wagner S., Liu K.F., Hu X.J. Neurological deficit and extent of neuronal necrosis attributable to middle cerebral artery occlusion in rats: statistical validation. Stroke 1995, 26:627-634.
11. Gong C., Hoff J.T., Keep R.F. Acute inflammatory reaction following experimental intracerebral hemorrhage in rat. Brain Res. 2000, 871:57-65.
12. Hawkins B.T., Egleton R.D. Fluorescence imaging of blood-brain barrier disruption. J. Neurosci. Methods 2006, 151:262-267.
13. Hua Y., Schallert T., Keep R.F., Wu J., Hoff J.T., Xi G. Behavioral tests after intracerebral hemorrhage in the rat. Stroke 2002, 33:2478-2484.
14. Ikram M.A., Wieberdink R.G., Koudstaal P.J. International epidemiology of intracerebral hemorrhage. Curr. Atheroscler. Rep. 2012, 14:300-306.
15. Itoh K., Chiba T., Takahashi S., Ishii T., Igarashi K., Katoh Y., et al. An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. Biochem. Biophys. Res. Commun. 1997, 236:313-322.
16. Jain A.K., Jaiswal A. Phosphorylation of tyrosine 568 controls nuclear export of Nrf2. J. Biol. Chem. 2006, 281:12132-12142.
17. Jain A.K., Bloom D.A., Jaiswal A.K. Nuclear import and export signals in control of Nrf2. J. Bio. Chem. 2005, 280:29158-29168.
18. Javaid K., Rahman A., Anwar N.K., Frey R.S., Minshall R.D., Malik A.B. Tumor necrosis factor-α induces early-onset endothelial adhesivity by protein kinase C-ζ dependent activation of intercellular adhesion molecule-1. Circ. Res. 2003, 92:1089-1097.
19. Kappos L., Gold R., Miller D.H., Macmanus D.G., Havrdova E., Limmroth V., et al. Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study. Lancet 2008, 372:1463-1472.
20. Keep R.F., Hua Y., Xi G. Intracerebral haemorrhage: mechanisms of injury and therapeutic targets. Lancet Neurol. 2012, 11(8):720-731.
21. Kensler T.W., Wakabayashi N., Biswa S. Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway. Annu. Rev. Pharmacol. Toxicol. 2007, 47:89-116.
22. Kim J., Cha Y., Surh Y. A protective role of nuclear factor-erythroid 2-related factor-2 (Nrf2) in inflammatory disorders. Mutat. Res. 2010, 690:12-23.
23. Kobayashi A., Kang M.I., Okawa H., Ohtsuji M., Zenke Y., Chiba T., et al. Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2. Mol. Cell. Biol. 2004, 24:7130-7139.
24. Lee J.M., Johnson J.A. An important role of Nrf2-ARE pathway in the cellular defense mechanism. J. Biochem. Mol. Biol. 2004, 37:139-143.
25. Lee J.M., Hanson J.M., Chu W.A., Johnson J.A. Phosphatidylinositol 3-kinase, not extracellular signal-regulated kinase, regulates activation of the antioxidant-responsive element in IMR-32 human neuroblastoma cells. J. Biol. Chem. 2001, 276:20011-20016.
26. Linker R.A., Lee D., Ryan S., van Dam A.M., Conrad R., Bista P., et al. Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway. Brain 2011, 134:678-692.
27. Ma Q., Manaenko A., Khatibi N.H., Chen W., Zhang J.H., Tang J. Vascular adhesion protein-1 inhibition provides antiinflammatory protection after an intracerebral hemorrhagic stroke in mice. J. Cereb. Blood Flow Metab. 2011, 31:881-893.
28. Ma Qingyi, Huang B., Khatibi N., Rolland W., Suzuki H., Zhang J.H., Jiping T. PDGFR-α inhibition preserves blood brain barrier after intracerebral hemorrhage. Ann. Neurol. 2011, 70:920-931.
29. Ma Q., Chen S., Hu Q., Feng H., Zhang J.H., Tang J. NLRP3 Inflammasome Contributes to inflammation after intracerebral hemorrhage. Ann Neurol 2014, 75:209-219.
30. MacLellan C.L., Silasi G., Poon C.C., Edmundson C.L., Buist R., Peeling J., et al. Intracerebral hemorrhage models in rat: comparing collagenase to blood infusion. J. Cereb. Blood Flow Metab. 2008, 28:516-525.
31. Manaenko A., Chen H., Kammerd J., Zhang J.H., Tang J. Comparison Evans Blue injection routes: intravenous versus intraperitoneal, for measurement of blood-brain barrier in a mice hemorrhage model. J. Neurosci. Methods 2011, 195:206-210.
32. Matsushita K., Meng W., Wang X., Asahi M., Asahi K., Moskowitz M.A., et al. Evidence for apoptosis after intercerebral hemorrhage in rat striatum. J. Cereb. Blood Flow Metab. 2000, 20:396-404.
33. Mullier M., Bouret S.G., Vincent Prevot V., Dehouck B.J. Differential distribution of tight junction proteins suggests a role for tanycytes in blood-hypothalamus barrier regulation in the adult mouse brain. J. Comp. Neurol. 2010, 518:943-962.
34. Numazawa S., Ishikawa M., Yoshida A., Tanaka S., Yoshida T. Atypical protein kinase C mediates activation of NF-E2-related factor 2 in response to oxidative stress. Am. J. Physiol. Cell Physiol. 2003, 285:C334-C342.
35. Ockenfels H.M., Schultewolter T., Ockenfels G., Funk R., Goos M. The antipsoriatic agent dimethylfumarate immunomodulates T-cell cytokine secretion and inhibits cytokines of the psoriatic cytokine network. Br. J. Dermatol. 1998, 139:390-395.
36. Pagano M., Poletto G., Di Maira G., Cozza G., Ruzzene M., Sarno S., et al. Tetrabromocinnamic acid (TBCA) and related compounds represent a new class of specific protein kinase CK2 inhibitors. Chem. Biol. Chem. 2007, 8:129-139.
37. Pandey A.S., Xi G. Intracerebral hemorrhage: a multimodality approach to improving outcome. Translat. Stroke Res. 2014, 5:313-315.
38. Pi J., Bai Y., Reece J.M., Williams J., Liu D., Freeman M.L., et al. Molecular mechanism of human Nrf2 activation and degradation: role of sequential phosphorylation by protein kinase CK2. Free Radic. Biol. Med. 2007, 42:1797-1806.
39. Rada P., Rojo A.I., Evrard-Todeschi N., Innamorato N.G., Cotte A., Jaworski T., et al. Structural and functional characterization of Nrf2 degradation by the GSK-3/β-TrCP axis. Mol. Cell. Biol. 2012, 32:3486-3499.
40. Rosenberg G.A., Mun-Bryce S., Wesley Mario, Kornfeld M. Collagenase-induced intracerebral hemorrhage in rats. Stroke 1990, 21:801-807.
41. Schallert T., Fleming S.M., Leasure J.L., Tillerson J.L., Bland S.T. CNS plasticity and assessment of forelimb sensorimotor outcome in unilateral rat models of stroke, cortical ablation, parkinsonism and spinal cord injury. Neuropharmacology 2000, 39:777-787.
42. Schlunk F., Schulz E., Lauer A., Yigitkanli K., Pfeilschifter W., Steinmetz, et al. Warfarin pretreatment reduces cell death and MMP-9 activity in experimental intracerebral hemorrhage. Translat. Stroke Res. 2014, 10.1007/s12975-014-0377-3.
43. Schmidt T.J., Muharrem A.K., Ulrich M. Reactivity of dimethyl fumarate and methylhydrogen fumarate towards glutathione and N-acetyl-l-cystein - preparation of S-substituted thiosuccinic acid esters. Bioorg. Med. Chem. 2007, 15:333-342.
44. Simard J.M., Kent T.A., Chen M., Tarasov K.V., Gerzanich V. Brain edema in focal ischemia: molecular pathophysiology and theoretical implications. Lancet Neurol. 2007, 6:258-268.
45. Stamatovic S.M., Keep R.F., Andjelkovic A.V. Brain endothelial cell-cell junctions: how to "open" the blood brain barrier. Curr. Neuropharmacol. 2008, 6:179-192.
46. Stoof T.J., Flier J., Sampat S., Nieboer C., Tensen C.P., Boorsma D.M. The antipsoriatic drug dimethylfumarate strongly suppresses chemokine production in human keratinocytes and peripheral blood mononuclear cells. Br. J. Dermatol. 2001, 144:1114-11120.
47. Supanc V., Biloglav Z., Kes V.B., Demarin V. Role of cell adhesion molecules in acute ischemic stroke. Ann. Saudi Med. 2011, 31:365-370.
48. Tang J., Liu J., Zhou C., Alexander J.S., Nanda A., Granger D.N., et al. MMP-9 deficiency enhances collagenase-induced intracerebral hemorrhage and brain injury in mutant mice. J. Cereb. Blood Flow Metab. 2004, 24:1133-1145.
49. Thimmulappa R.K., Lee H., Rangasamy T., Reddy S.P., Yamamoto M., Kensler T.W., et al. Nrf2 is a critical regulator of the innate immune response and survival during experimental sepsis. J. Clin. Invest. 2006, 116:984-995.
50. Wang J., Doré S. Inflammation after intracerebral hemorrhage. J. Cereb. Blood Flow Metab. 2007, 27:894-908.
51. Wang J., Fields J., Dore S. The development of an improved preclinical mouse model of intracerebral hemorrhage using double infusion of autologous whole blood. Brain Res. 2008, 1222:214-221.
52. Xiong X.Y., Wang J., Qian Z.M., Yang Q.W. Iron and intracerebral hemorrhage: from mechanism to translation. Translat. Stroke Res. 2014, 5:429-441.
53. Zhang M., An C., Gao Y., Leak R.K., Chen J., Zhang F. Emerging roles of Nrf2 and phase II antioxidant enzymes in neuroprotection. Prog. Neurobiol. 2013, 100:30-47.
54. Zhao X., Aronowski J. Nrf2 to pre-condition the brain against injury caused by products of hemolysis after ICH. Translat Stroke Res. 2013, 4:71-75.
55. Zhao X., Sun G., Zhang J., Strong R., Dash P.K., Kan Y.W., et al. Transcription factor Nrf2 protects the brain from damage produced by intracerebral hemorrhage. Stroke 2007, 38:3280-3286.
56. Zhao X., Sun G., Zhang H., Ting S.M., Song S., Gonzales N., et al. Polymorphonuclear neutrophil in brain parenchyma after experimental intracerebral hemorrhage. Translat. Stroke Res. 2014, 5:554-561.